Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-08-01T16:19:45.896Z Has data issue: false hasContentIssue false

Chapter 60 - Cord Blood Cell Transplants: Donor Selection, Volume, and Controversies

from Section 16 - Novel Transplant Strategies

Published online by Cambridge University Press:  24 May 2017

By
Karen K. Ballen
Edited by
Hillard M. Lazarus ,
Robert Peter Gale ,
Armand Keating ,
Andrea Bacigalupo ,
Reinhold Munker  and
Kerry Atkinson
Edited in association with
Syed Ali Abutalib
Hillard M. Lazarus
Affiliation:
Case Western Reserve University, Ohio
Robert Peter Gale
Affiliation:
Imperial College London
Armand Keating
Affiliation:
University of Toronto
Andrea Bacigalupo
Affiliation:
Ospedale San Martino, Genoa
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Kerry Atkinson
Affiliation:
University of Queensland
Syed Ali Abutalib
Affiliation:
Midwestern Regional Medical Center, Cancer Treatment Centers of America, Chicago
Get access
Type
Chapter
Information
Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
 , pp. 569 - 578
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Broxmeyer, HE, Gordon, GW, Hangoc G, G, et al. Human umbilial cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86.10: 3828–32.CrossRefGoogle Scholar
Gluckman, E, Broxmeyer, HE, Auerbach, AD, et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical-cord blood from an HLA-identical sibling. N Eng J Med 1989;321.17: 1174–78.CrossRefGoogle Scholar
Auerbach, AD, Liu, O, Ghosh, R, et al. Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi anemia. Transfusion 1990;30.8: 682–7.CrossRefGoogle ScholarPubMed
Rubinstein, P, Dobrila, L,Rosenfield, RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92: 10119–22.CrossRefGoogle ScholarPubMed
Kurtzberg, J, Laughlin, M, Graham, ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. New Engl J Med 1996;335.3: 157–66.CrossRefGoogle ScholarPubMed
Wagner, JE, Barker, JN, Defor, TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases. Blood 2002;100: 1611–8.CrossRefGoogle ScholarPubMed
Rocha, V, Cornish, J, Sievers, E. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2010;97.10: 2962–71.Google Scholar
Eapen, M, Rubinstein, P, Zhang, MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study . Lancet 2007;369.9577: 1947–54.CrossRefGoogle ScholarPubMed
Prasad, VK, Mendizabal, A, Parikh, SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composisiton of the graft on transplantation outcomes. Blood 2008;112.7: 2979–89.CrossRefGoogle ScholarPubMed
Wagner, JE, Eapen, M, Carter, SL, et al. No survival advantage after double vs single cord blood transplantation in children with hematologic malignancy. Blood 2012;120.21: 359a.CrossRefGoogle Scholar
Laughlin, MJ, Barker, J, Bambach, B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344.24: 1815–22.CrossRefGoogle ScholarPubMed
Ooi, J, Takahashi, S, Tomonari, A, et al. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogeneous leukemia. Biol Blood Marrow Transplant 2008;14.12: 1341–47.Google Scholar
Mori, T, Tanaka, S, Tsukada, N, et al. Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk malignancies. Biol Blood Marrow Transplant 2013;19: 486–91.CrossRefGoogle Scholar
Sanz, J, Boluda, JC, Martin, C, et al. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematologic malignancy using busulfan, thiotepa, fludarabine, and ATG as myeloablative conditioning regimen. Bone Marrow Transplant 2012;47.10: 1287–93.CrossRefGoogle ScholarPubMed
Ballen, KK, Gluckman, E, Broxmeyer, H. Umbilical cord blood transplantation: The first 25 years and beyond. Blood 2013;122.4: 491–8.CrossRefGoogle ScholarPubMed
Barker, JN, Weisdorf, DJ, DeFor, TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced intensity conditioning. Blood 2003;102.5: 1915–19.CrossRefGoogle ScholarPubMed
Ballen, KK, Spitzer, TR, Yeap, BY, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007;13.1: 82–89.CrossRefGoogle ScholarPubMed
Cutler, C, Stevenson, K, Kim, HT, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus based GVHD prophylaxis. Bone Marrow Transplant 2011;46.5: 273–77.CrossRefGoogle ScholarPubMed
Ramirez, P, Wagner, JE, DeFor, TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant 2012;47.6: 799–803.CrossRefGoogle ScholarPubMed
Verneris, MR, Brunstein, CG, Barker, J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 2009;114.9: 4293–9.CrossRefGoogle ScholarPubMed
Labopin, M, Ruggeri, M, Gorin, NC, et al. Cost-effectiveness and clinical outcomes of double vs single cord blood transplants in adults with acute leukemia in France. Leukemia 2014;99.3: 535–40.Google ScholarPubMed
Barker, JN, Scaradavou, A, Stevens, CE, et al. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 2010;115.9: 1843–49.CrossRefGoogle ScholarPubMed
Takanashi, M, YAtsuta, K Fujiwara, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010;116.15: 2839–46.CrossRefGoogle ScholarPubMed
Cutler, C C, Kim, HT, Sun, L, et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood 2011;118.25: 6691–97.CrossRefGoogle ScholarPubMed
van Rood, JJ, Stevens, CE, Smits, J, et al. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcomes in hematological malignancies. Proc Natl Acad Sci USA 2009;106.47: 19952–7.CrossRefGoogle ScholarPubMed
Rocha, V, Spellman, S, Zhang, MJ, et al. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2012;18.12: 1890–96.CrossRefGoogle ScholarPubMed
Eapen, M, Klein, JP, Sanz, GF, et al. Effect of donor-recipient matching at HLA A, B, C and DRB1 on outcomes after umbilical cord blood transplantation for leukemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011;12.13: 1214–21.CrossRefGoogle Scholar
Garfall, A, Kim, H, Cutler, C, et al. Allele level matching at HLA-C or DRB1 is associated with improved survival after reduced intensity cord blood transplantation. Blood 2012;120.21: 2010a (Abstract).CrossRefGoogle Scholar
Eapen, M, Klein, JP, Ruggeri, A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood 2014;123.1: 133–40.CrossRefGoogle ScholarPubMed
Garfall, A, Kim, HT,Sun, L, et al. KIR-ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation. Bone Marrow Transplant 2013 ;48.7: 1000–2.CrossRefGoogle Scholar
Brunstein, CG, Wagner, JE, Weisdorf, DJ, et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplants depends on transplantation conditioning intensity. Blood 2009;113.22: 5628–34.CrossRefGoogle ScholarPubMed
Willemze, R, Rogrigues, CA, Labopin, M, et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord transplantation for acute leukemia. Leukemia 2009;23.3: 492–500.CrossRefGoogle ScholarPubMed
Smith, KM. Analysis of 402 cord blood units to assess factors influencing infused viable CD 34+ cell dose: the critical determinant of engraftment. Blood 2013;122.21: 296–300.Google Scholar
Eapen, M, Rocha, V, Sanz, G, et al. Effect of graft source on unrelated donor hematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol 2010;11.7: 653–60.CrossRefGoogle ScholarPubMed
Brunstein, CG, Gutman, JA, Weisdorf, DJ, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010;116.22: 4693–9.CrossRefGoogle ScholarPubMed
Chen, YB, Aldridge, J, Kim, HT, et al. Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts. Biology Blood Marrow Transplant 2012;8: 805–12.Google Scholar
Brunstein, CG, Eapen, M, Ah, KW, et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood 2012;119.23: 5591–98.CrossRefGoogle ScholarPubMed
Milano, F, Gooley, T, Wood, B, et al. Cord-blood transplantation in patients with minimal residual disease. New Engl J Med 2016;375(10): 444-53.CrossRefGoogle Scholar
Brunstein, CG, Fuchs EJ, EJ, Carter, SJ, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011 ;118.2: 282–88.CrossRefGoogle ScholarPubMed
Bautista, G, Cabreza, JR, Regidor, C, et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplant 2009;43.5: 365–73.CrossRefGoogle ScholarPubMed
Liu, H, Rich, ES, Godley, L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011;118.24: 6438–45.CrossRefGoogle ScholarPubMed
Ponce, DM, Dahi, PB, Devlin, S, et al. Double-unit cord blood transplantation combined with haplo-identical CD34+ selected PBSC results in 100% CB engraftment and enhanced myeloid recovery. Blood 2013;122: 298.Google Scholar
Frassoni, F, Gualandi, F, Podesta, M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukemia: a phase I/II study. Lancet Oncol 2008;9.9: 831–39.CrossRefGoogle ScholarPubMed
Brunstein, C, Barker, JN, Weisdorf, DJ, et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant 2009;43.12: 935–40.CrossRefGoogle ScholarPubMed
Delaney, C, Heimfeld, S, Brashem-Stein, C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nature Med 2010;16.2: 232–36.CrossRefGoogle ScholarPubMed
de Lima, M, McNiece, I, Robinson, SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 2012;367.24: 2305–15.CrossRefGoogle ScholarPubMed
Horwitz, ME, Chao, NJ. Rizzieri, DA, et al. Umbilical cord blood expansion with nicotinamide provides long-term mulitlineage engraftment. J Clin Invest 2014;124.7: 3121–8.CrossRefGoogle ScholarPubMed
Montesinos P, P, Peled, T, Landau, E, et al. Stem-Ex (copper chelation based) ex vivo expanded cord blood umbilical cord blood stem cell transplantation (UCBT) accelerates engraftment and improves 100 day survival in myeloablated patients compared to a registry cohort undergoing double-unit UCBT: results of a multicenter study of 101 patients with hematologic malignancies. Blood 2013;122: 295 (Abstract).Google Scholar
Goessling, W, Allen, RS, Guan, X, et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Stem Cell 2011;8.4: 445–58.Google ScholarPubMed
Cutler, C, Multani, P, Robbins, D, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 2013;122: 3074–81.CrossRefGoogle ScholarPubMed
Popat, UR, Oran B, B, Hosing, CM, et al. Ex vivo fucosylation of cord blood accelerates neutrophil and platelet engraftment. Blood 2013;122: 691–95.CrossRefGoogle Scholar
Farag, SS, Srivastava, S, Messina-Graham, S, et al. In-vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematologic malignancies. Stem Cell Dev 2013;22: 1007–15.CrossRefGoogle Scholar
Norkin, M, Lazarus, HM, Wingard, JR. Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic? Bone Marrow Transplant 2013;48.7: 884–9.CrossRefGoogle ScholarPubMed
Sauter, C, Abboud, M, Jia, X, et al. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biol Blood Marrow Transplant 2011;17.10: 1–12.CrossRefGoogle ScholarPubMed
Hanley, P P, Cruz, CR, Savoldo, B, et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood 2009;114.9: 1958–67.CrossRefGoogle Scholar
Brunstein, CG, Miller, J, Cao, Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011;117.3: 1061–70.CrossRefGoogle ScholarPubMed
Ballen, KK, Klein, JP, Pedersen, TL, et al. Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes. Biol Blood Marrow Transplant 2012;18.6: 903–12.CrossRefGoogle Scholar
Ballen, KK, Joffe, S, Brazauskas, R, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources. Biol Blood Marrow Transplant 2014;20.11:1819–27.CrossRefGoogle ScholarPubMed
Deuse, T, Stubbendorff, M. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 2011;20.5: 655–67.CrossRefGoogle ScholarPubMed
Cui, X, Choppe, M, Zacharek, A, et al. Combination treatment of stroke with subtherapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcomes. Neuroscience 2012;227: 223–31.CrossRefGoogle Scholar
Cotten, CM, Murtha, AP, Goldberg, RN, et al. Feasibility of autologous cord blood cells for infants wtih hypoxic-ischemic encephalopathy. J Pediatr 2014;164: 973–9.CrossRefGoogle Scholar
Barker, JN, Byam, C, Scaradavou, A. How I treat: the selection and acquisition of unrelated cord blood grafts. Blood 2011;117.8: 2332–9.CrossRefGoogle Scholar
Ponce, DM, Zheng, J, Gonzales, AM, et al. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17.9: 1316–26.CrossRefGoogle ScholarPubMed
Marks, DI, Woo, KA, Zhong, X, et al. Unrelated umbilical cord blood transplantation for adult acute lymphoid leukemia in first or second complete remission. Hematologica. 2014;99.2: 322–8.CrossRefGoogle ScholarPubMed
Sun, J, Allison, J, McLaughlin, C, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion 2010;50.9: 1980–7.CrossRefGoogle ScholarPubMed
Jeevanantham, V, Butler, M, Saad, A, et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012;126.5: 551–68.CrossRefGoogle ScholarPubMed
Haller, MJ, Wasserfall, CH, Hulme, MA, et al. Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin D supplementation for C-peptide preservation in children with Type 1 diabetes. Biol Blood Marrow Transplant 2013;19.7: 1126–9.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×